Overview
Antibiotic resistance is a serious public health crisis. As resistance to antibiotics grows, it becomes increasingly difficult to effectively manage a wide range of infections, which often results in poor outcomes for patients and escalating healthcare costs. Our vision is to improve patients’ health and outcomes by creating innovative, life-saving medicines to treat serious infectious diseases caused by drug-resistant Gram-negative bacteria.